Sakk 38/19: Assessing a CTDNA and Pet-Oriented Therapy in Patients with DLBCL. A Multicenter, Open-Label, Phase II Trial.
Stathis A., Hitz F., Schär S., Novak U., Fischer N., Mey U., Gritti G., Zander T., Lang N., Cairoli A. et al., 2023/06., 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, 13 ‐ 17 June, 2023 pp. 165-166 dans Hematological oncology. Peer-reviewed.
ici le détail